PSMB8 and urinary bladder carcinoma: A study of epithelial–mesenchymal transition-related lncRNA signature correlating with the prognosis and progression in patients with bladder cancer suggests that PSMB8-AS1 and AC073534.1 could be used to predict the prognosis and progression of bladder cancer patients [29].